摘要
目的观察参芎葡萄糖注射液对冠心病患者治疗前后缺血修饰白蛋白(IMA)的影响。方法将94例冠心病患者按照随机数字表法分为对照组和治疗组,每组各47例,对照组采用西医常规治疗,治疗组在对照组的基础上使用参芎葡萄糖注射液100ml静脉滴注2次/日。结果治疗组治疗后缺血修饰白蛋白(IMA)较治疗前有明显改善,与对照组治疗后比较,差异有统计学意义(P<0.05)。结论参芎葡萄糖注射液能使冠心病患者体内缺血修饰白蛋白有明显下降,其治疗机制可能与改善冠脉供血有关。
Objective To investigate the effect of Shenxiong glucose injection on ischemia-modified albumin（IMA） in patients with coronary heart disease. Methods A total of 94 patients with coronary heart disease were divided into control group and treatment group according to the random number table, with 47 patients in each group. The patients in the control group received conventional Western medicine treatment, and those in the treatment group were given an intravenous drip of Shenxiong glucose injection（100ml） twice a day in addition to the conventional Western medicine treatment. Results After treatment, the treatment group had a significant reduction in IMA, and IMA showed a significant difference between the two groups（P0.05）. Conclusion Shenxiong glucose injection can significantly reduce IMA in patients with coronary heart disease, and its therapeutic mechanism may be related to the improvement in coronary blood supply.
出处
《心血管病防治知识（学术版）》
2016年第2期28-29,共2页
Prevention and Treatment of Cardiovascular Disease
关键词
冠心病
参芎葡萄糖注射液
缺血修饰白蛋白
Coronary heart disease
Shenxiong glucose injection
Ischemia-modified albumin
